Jointly headed by Joseph and Adi Zaltzman, J Zaltzman Gilat Knoller Graus Salomon & Co’s seven-lawyer strong capital markets practice has been active preparing prospectuses for a number of Israeli companies to enable fundraising, including: Ilex Medical, Leader Investments and Holdings and, Carmel Olfins.
Debt has proven an active area for the firm and it has assisted a number of companies with settling outstanding issues with bond holders....
[more]
Jointly headed by Joseph and Adi Zaltzman, J Zaltzman Gilat Knoller Graus Salomon & Co’s seven-lawyer strong capital markets practice has been active preparing prospectuses for a number of Israeli companies to enable fundraising, including: Ilex Medical, Leader Investments and Holdings and, Carmel Olfins.
Debt has proven an active area for the firm and it has assisted a number of companies with settling outstanding issues with bond holders. Acting for Polar Communications, Adi Zaltzman led a team assisting in paying of its NIS100 million ($26 million) debt to holders of corporate bonds in July 2010. The firm assisted also SR Accord Technologies in undertaking a similar arrangement.
Restructuring has been a mainstay from the firm’s banking practise recently. The firm’s most substantial deal sees it advising the KMN group on settling its NIS1.5 billion accumulated between five major Israeli banks - Bank Hapoaalim, Bank Leumi le Israel, Israel Discount Bank, Israel Mercantile Bank, Mizrahi Tefahot Bank, and some foreign institutions. Completed mandates has seen the firm assist SR Accord, Kibbutz Ein Harod and Kibbutz Kfar Aza on settling debt with Israeli banks of NIS50 million, NIS47.5 million and NIS21 million respectively.
The firm also completed a piece of acquisition finance work, acting Ilex Medical in securing the funds to purchase 54% of Medtechnica for NIS190 million in March 2011.
In addition to assisting with accruing the funds for Ilex Medical’s deal with Medtechnica, the corporate team also handled the acquisition. Joint practice head Joseph Zaltzman led the team, which negotiated the NIS257 million deal. $0$0In a further mandate on the M&A side, the firm acted for Albaad Massuot Yitzhak on its $65 million acquisition of Rostam in August 2010.
Another mandate on the buy side saw the firm act for Elcam Medical in purchasing an Italian company, engaged in the manufacture, distribution and marketing of disposable components for the medical industry, for approximately NIS150 million in December 2010.
[hide]